14-year-old Ashley Silverman narrowly avoided death after experiencing a severe medical emergency due to taking the prescription drug Lamictal for mood swings. The FDA issued a warning about the potential deadly side effects of Lamictal, specifically Stevens-Johnson Syndrome, a rare and serious immune reaction that can be triggered by medications. Ashley’s father was unaware of this risk when she started taking the medication, and Ashley ended up in the ICU with severe symptoms. This incident highlights the importance of recognizing early symptoms of SJS and raises questions about mental health treatment in adolescents.
The FDA warns that Lamictal can cause a serious and potentially fatal immune reaction known as Stevens-Johnson Syndrome. This reaction can lead to severe inflammation and hospitalization if not promptly diagnosed and treated.
Stevens-Johnson Syndrome can be triggered by various medications and infections, and its symptoms can often be mistaken for common conditions. Recognizing the signs of SJS early is crucial as it can lead to organ failure and death in severe cases. Ashley’s experience sheds light on the importance of understanding and monitoring mental health in adolescents, as mood swings could be a sign of a more serious condition.
What should the public know about Stevens-Johnson Syndrome?
SJS is an exaggerated immune response triggered by medications or infections, with symptoms including fever, rash, blisters, and difficulty breathing. About 1 in 10 people with SJS die from complications, emphasizing the severity of this condition. Ashley’s case serves as a warning about the potential dangers of medications and the importance of mental health awareness in young individuals.
When should you be worried about mood swings in adolescents?
Recognizing signs of mood disorders in adolescents, such as persistent sadness, disinterest in activities, and changes in behavior, is crucial for early intervention. Monitoring the severity, duration, and domains of mood changes can help in identifying potential mental health issues in young individuals. Ashley’s story highlights the need for better awareness and communication about mental health and medication risks in teenagers.
Sources
- “Stevens-Johnson syndrome.” Rare Diseases
- “Mood Disorders in Teens.” Stanford Children
- “Distinguishing depression from normal adolescent mood swings.” Harvard. Ann MacDonald. September 13, 2010.
- “Medical board launches investigation after teen’s skin ‘melts’ off in severe reaction to medication.” KTVU. Bill Melugin. March 12, 2019.
This article is originally from April 2019 and has since been updated.
.
